Documents the explosion of research efforts surrounding this fascinating human pathogen. This informative work offers a full account of the hepatitis delta virusfrom its natural history and diagnosis to its prevention and treatment. Using modern molecular techniques, renowned investigators reveal the pathogenic potential of HDV and its ability to variate at the genetic level. Presents initial studies of the therapeutic control of HDV and its role as a complication in liver transplantation programs. It also examines current vaccination programs for hepatitis B and their exciting, potential applications for control of HDV.
|Series:||Progress in Clinical and Biological Research Series , #143|
|Product dimensions:||1.38(w) x 2.24(h) x (d)|
Table of Contents
Partial table of contents:
EPIDEMIOLOGY OF TYPE D HEPATITIS.
Epidemiology of Hepatitis Delta Virus Infection in Less Developed Countries (S. Hadler, et al.).
DIAGNOSIS, NATURAL HISTORY, AND PATHOGENESIS OF TYPE D HEPATITIS.
Factors Influencing the Natural Course of HDV Hepatitis (F. Bonino, et al.).
VIROLOGY OF HEPATITIS DELTA VIRUS.
Functional Studies of Hepatitis Delta Antigen and Delta Virus RNA (M. Lai, et al.).
PREVENTION AND TREATMENT OF TYPE D HEPATITIS IN HIGH RISK POPULATIONS.
Hepatitis Delta Infection Among Multiply-Transfused Hemophiliacs (S. Lemon. et al.).
Long Term Treatment of Chronic Delta Hepatitis with Alpha Recombinant Interferon (G. Marinucci, et al.).